Citalopram hydrobromide and Nystatin drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Citalopram hydrobromide (citalopram hydrobromide) and Nystatin (nystatin). Common drug interactions include nausea among females and dyspnoea among males.
The phase IV clinical study analyzes what interactions people have when they take Citalopram hydrobromide and Nystatin. It is created by eHealthMe based on reports of 255 people who take the same drugs from the FDA, and is updated regularly.
What is Citalopram hydrobromide?
Citalopram hydrobromide has active ingredients of citalopram hydrobromide. It is often used in depression. eHealthMe is studying from 36,880 Citalopram hydrobromide users. Check the latest studies of Citalopram hydrobromide.
What is Nystatin?
Nystatin has active ingredients of nystatin. It is often used in thrush. eHealthMe is studying from 33,568 Nystatin users. Check the latest studies of Nystatin.
255 people who take Citalopram hydrobromide and Nystatin together, and have interactions are studied.
What are the common drug interactions of Citalopram hydrobromide and Nystatin, by gender? *
What are the common drug interactions of Citalopram hydrobromide and Nystatin, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Citalopram hydrobromide and Nystatin?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Citalopram hydrobromide (36,880 reports)
- Nystatin (33,568 reports)
Browse all drug interactions of Citalopram hydrobromide and Nystatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Citalopram hydrobromide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Nystatin:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Citalopram hydrobromide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Nystatin and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
- Hosseini, S. H., & Ahmadi, A., "Peripheral edema occurring during treatment with risperidone combined with citalopram", Case reports in medicine, 2012 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on citalopram hydrobromide and nystatin (the active ingredients of Citalopram hydrobromide and Nystatin, respectively), and Citalopram hydrobromide and Nystatin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Metoprolol Succinate and Xermelo - 4 seconds ago
- Sinemet and Hypokalemic Syndrome for Women aged 60+ - 7 seconds ago
- Sinemet and Hypokalaemic Syndrome for Women aged 60+ - 8 seconds ago
- Sinemet and Hypopotassemia for Women aged 60+ - 8 seconds ago
- Sinemet and Hypokalaemia for Women aged 60+ - 8 seconds ago
- Sinemet and Potassium - Low for Women aged 60+ - 9 seconds ago
- Sinemet and Low Blood Potassium for Women aged 60+ - 9 seconds ago
- Sinemet and Hypokalemia for Women aged 60+ - 10 seconds ago
- Could Remicade cause Ovarian Cancer? - 15 seconds ago
- Muscle Cramps and drugs of ingredients of fentanyl citrate - 15 seconds ago